[Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].

MLA

Dietlein, M., et al. “[Guidelines for Radioiodine Therapy (RIT) in Differentiated Thyroid Cancer].” Nuklearmedizin. Nuclear Medicine, vol. 38, no. 6A, 1999, pp. 221–22. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10510812&authtype=sso&custid=ns315887.

APA

Dietlein, M., Dressler, J., Farahati, J., Leisner, B., Moser, E., Reiners, C., Schicha, H., & Schober, O. (1999). [Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer]. Nuklearmedizin. Nuclear Medicine, 38(6A), 221–222.

Chicago

Dietlein, M, J Dressler, J Farahati, B Leisner, E Moser, C Reiners, H Schicha, and O Schober. 1999. “[Guidelines for Radioiodine Therapy (RIT) in Differentiated Thyroid Cancer].” Nuklearmedizin. Nuclear Medicine 38 (6A): 221–22. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10510812&authtype=sso&custid=ns315887.